PRE-FORUM WORKSHOP

Pediatric Oncology in Developing Countries: Focus on Southeast Asia

Date: Wednesday 6^th and Thursday 7^th March 2013

“No child should die in the dawn of life.”

- Danny Thomas
Founder of St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Presentations From SJVF 2012

Advances in Monitoring Minimal Residual Leukemia
CAMPANA, Dario, MD PhD
Professor
Department of Pediatrics,
National University of Singapore

Recent Advances in ALL
PUI, Ching-Hon MD
American Cancer Society Professor and Chair,
Department of Oncology,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Childhood ALL: Induction Protocols: Are We All Set?
VEERMAN, Anjo, MD
Emeritus Professor of Pediatrics, Vrije Universiteit,
Amsterdam, The NETHERLANDS
Visiting Professor of Pediatrics, Gadjah Mada University,
Jogjakarta, INDONESIA

Updates on UK ALL 97/99 and 2003
VORA, Ajay, MD
Professor, Pediatric Hematology
Specialist, Bone Marrow Transplantation
Department of Hematology
Sheffield Children’s Hospital
South Yorkshire, UK

Acute Promyelocytic Leukemia in Children
RIBEIRO, Raul MD
Professor and Director, Division of Leukemia/Lymphoma,
Director, International Outreach Program,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Advances in Pediatric AML
GIBSON, Brenda
Consultant Pediatric Hematologist Oncologist
Department of Hematology,
The Royal Hospital for Sick Children,
Glasgow, UK

Prolonged Tyrosine Kinase Inhibitor Therapy or Stem Cell Transplantation In Children and Adolescents with CML: Open Ended Versus Curative Therapy
YANIV, Isaac MD
Chairman, Pediatric Hematology Oncology and Stem Cell Transplantation
Schneider Children's Medical Center of Israel
Associate Professor of Pediatrics, Tel Aviv University
Chairman, Israeli Society of Pediatric Hematology Oncology(ISPHO)
Tel Aviv, ISRAEL

Updates in Supportive Care for Children with Acute Leukemia
HOWARD, Scott, MD, MSc
Chair, Pediatric Oncology in Developing Countries, SIOP
Director of Clinical Trials, International Outreach Program
Pediatric Oncology, Division of Leukemia and Lymphoma
Medical Information Officer
St. Jude Children's Research Hospital
Memphis, Tennessee, USA

BACK TO TOP

Allogeneic Cell Therapy: Where do we Stand
HANDGRETINGER, Rupert, MD
Professor and Chairman,
Department of Hematology/Oncology and General Pediatrics Children’s University Hospital,
Tuebingen, GERMANY

Overcoming Barriers in Transplantation
LEUNG, Wing, MD PhD
Director, Division of Bone Marrow Transplant and Cellular Therapy,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

BACK TO TOP

Neuroblastoma: Therapeutic Strategies for a Clinical Enigma
CHEUNG, Nai-Kong V. MD PhD
Enid A. Haupt Chair in Pediatric Oncology
Member and Attending, Department of Pediatrics
Director, Neuroblastoma Program
Head, Robert Steel Laboratory
Memorial Sloan-Kettering Cancer Center
New York, USA

Advances in the Treatment of Neuroblastoma: the COG Approach
COHN, Susan, MD
Professor and Director of Pediatric Clinical Sciences
Department of Pediatrics
University of Chicago
Chicago, Illinois, USA

Childhood Rhabdomyosarcoma in Asia – Practical Concepts for Countries with Diverse Resources
RODRIGUEZ-GALINDO Carlos, MD
Associate Professor, Department of Pediatrics, Harvard Medical School
Director, Solid Tumor Program, Pediatric Oncology, Dana-Farber Cancer Institute
Medical Director, Pediatric Oncology Clinical Trials, Pediatric Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, USA

BACK TO TOP

ORGANIZERS